Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Garg

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 31, 2004
Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in IndiaN A Kshirsagar, N J Gogtay, B S Garg, et al.
Open Forum Infectious Diseases|May 25, 2026
Performance of TB Antigen-Based Skin Tests Amongst Healthcare Workers-Sevagram, India, 2023-2024P V Shivkumar, A Rannaware, R D Deshmukh, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Vaccine|April 9, 2019
Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infantsAnand Kawade, Sudhir Babji, Veena Kamath, et al.
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
The Lancet. Infectious Diseases|November 9, 2024
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 studyPrasad S Kulkarni, Anand Kawade, Sunil Kohli, et al.
Plos One|March 6, 2023
SCOPE: Surveillance of COVID-19 in pregnancy- results of a multicentric ambispective case-control study on clinical presentation and maternal outcomes in India between April to November 2020Sunesh Kumar, Neerja Bhatla, K Aparna Sharma, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 31, 2004
Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in IndiaN A Kshirsagar, N J Gogtay, B S Garg, et al.
Open Forum Infectious Diseases|May 25, 2026
Performance of TB Antigen-Based Skin Tests Amongst Healthcare Workers-Sevagram, India, 2023-2024P V Shivkumar, A Rannaware, R D Deshmukh, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Vaccine|April 9, 2019
Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infantsAnand Kawade, Sudhir Babji, Veena Kamath, et al.
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
The Lancet. Infectious Diseases|November 9, 2024
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 studyPrasad S Kulkarni, Anand Kawade, Sunil Kohli, et al.
Plos One|March 6, 2023
SCOPE: Surveillance of COVID-19 in pregnancy- results of a multicentric ambispective case-control study on clinical presentation and maternal outcomes in India between April to November 2020Sunesh Kumar, Neerja Bhatla, K Aparna Sharma, et al.
Pageof 7